Correlation Between Vincerx Pharma and Aerovate Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Aerovate Therapeutics, you can compare the effects of market volatilities on Vincerx Pharma and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Aerovate Therapeutics.

Diversification Opportunities for Vincerx Pharma and Aerovate Therapeutics

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vincerx and Aerovate is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Aerovate Therapeutics go up and down completely randomly.

Pair Corralation between Vincerx Pharma and Aerovate Therapeutics

Given the investment horizon of 90 days Vincerx Pharma is expected to under-perform the Aerovate Therapeutics. In addition to that, Vincerx Pharma is 9.59 times more volatile than Aerovate Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest  253.00  in Aerovate Therapeutics on October 20, 2024 and sell it today you would earn a total of  5.00  from holding Aerovate Therapeutics or generate 1.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vincerx Pharma  vs.  Aerovate Therapeutics

 Performance 
       Timeline  
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Aerovate Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Vincerx Pharma and Aerovate Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vincerx Pharma and Aerovate Therapeutics

The main advantage of trading using opposite Vincerx Pharma and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.
The idea behind Vincerx Pharma and Aerovate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like